mafosfamide has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maki, PA; Sladek, NE | 1 |
| Engel, J; Hilgard, P; Leibfritz, D; Sonawat, HM | 1 |
| Hilgard, P; Holtei, W; Iselt, M | 1 |
3 other study(ies) available for mafosfamide and Leukemia P388
| Article | Year |
|---|---|
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Hematopoietic Stem Cells; Inactivation, Metabolic; Kinetics; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Phosphoramide Mustards; Procarbazine | 1991 |
Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cyclophosphamide; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Phosphorus; Tumor Cells, Cultured | 1990 |
The tetrazolium dye assay for rapid in vitro assessment of cytotoxicity.
Topics: Animals; Antineoplastic Agents; Cell Survival; Crystallization; Cyclophosphamide; Formazans; Leukemia P388; Mice; Tetrazolium Salts; Tumor Cells, Cultured | 1989 |